Cytrx Stock Price - CYTR

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cytrx CYTR NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 0.31 0.00 0.00 0.00 0.31 20:00:00
Bid Price Ask Price Spread Spread % News
0.30 0.3001 0.00 0.00% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Cytrx Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 10.43M 33.64M $ -12.71M -0.42 -0.82 32.26M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
294.31k $ - 0.00% - -

more financials information »

Cytrx News

Latest CYTR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYTR Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0000.00000--
1 Month0000.00000--
3 Months0.560.720.30.4677250k-0.25-44.64%
6 Months0.6050.77890.30.5787178k-0.295-48.76%
1 Year1.
3 Years3.83165.9880.33.54642M-3.5216-91.91%
5 Years2132.520.37.36621M-20.69-98.52%

Cytrx Description

CytRx Corp is a biopharmaceutical research and development company in the United States. Its key drug candidate is aldoxorubicin, which is developed to address serious diseases such as soft tissue sarcoma (STS).

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.